AlmirallLBTSF 85 Pretax Margin % is 8.00% as of Mar. 2026, which is 55% above its 10-year median of 5.16. GuruFocus rates LBTSF with a GF Score™ of 85/100 and a GF Value™ of $16.92. The stock has 4 warning signs investors should review. Among 955 Drug Manufacturers companies, Almirall ranks worse than 53.4% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Almirall's Pre-Tax Income for the
three
months ended in Mar. 2026 was $27 Mil. Almirall's Revenue for the
three
months ended in Mar. 2026 was $338 Mil. Therefore, Almirall's pretax margin for the quarter that ended in Mar. 2026 was 8.00%.
The historical rank and industry rank for Almirall's Pretax Margin % or its related term are showing as below:
LBTSF'
s Pretax Margin % Range Over the Past 10 Years
Min: -50.21 Med: 5.16 Max: 12.12
Current: 6.04
LBTSF's Pretax Margin % is ranked worse than 53.4% of 955
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs LBTSF: 6.04
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Almirall Pretax Margin % Related Terms
Almirall Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Almirall's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBTSF vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almirall Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Almirall's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Almirall's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almirall (LBTSF) has a Pretax Margin % of 8.00% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Almirall and its competitors. This is 55% above median its historical median of 5.16. According to the industry distribution chart, Almirall ranks #510 out of 955 companies in the Drug Manufacturers industry, placing it in the top 53.4%.
Is Almirall's Pretax Margin % too high?
Almirall's current Pretax Margin % of 8.00% is 55% above median its 10-year median of 5.16. The Drug Manufacturers industry median Pretax Margin % is 7.28. Almirall's value of 8.00% is 9.9% above this industry median. Based on the distribution chart, Almirall ranks #510 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Almirall ranks #510 out of 955 companies for Pretax Margin %. This places Almirall in the lower half of its industry. The industry median Pretax Margin % is 7.28. Almirall's value of 8.00% is 9.9% above this benchmark. While the company's 10-year median is 5.16 vs. the industry median of 7.28, Almirall has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almirall's current Pretax Margin % of 8.00% is 9.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Almirall and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almirall's current Pretax Margin % is 8.00%, which is 55% above median its own 10-year median of 5.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Pretax Margin % of 8.00%. The stock's GF Value™ is $16.92, compared to a current price of $15.35 — trading 9.3% below its estimated fair value. The current Pretax Margin % is 8.00%, which is 55% above median its 10-year median of 5.16 and 9.9% above the Drug Manufacturers industry median of 7.28. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Almirall (LBTSF), the current Pretax Margin % is 8.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Almirall (LBTSF) Overvalued in 2026?
Based on GuruFocus' analysis, Almirall stock appears to be undervalued.
The current stock price of $15.35 is trading 9.3% below its estimated GF Value™ of $16.92.
Key valuation signals for LBTSF:
Pretax Margin %: 8.00% (55% above median its 10-year median of 5.16)
GF Value™: $16.92 vs. price of $15.35 (9.3% below fair value)
Industry Position: 9.9% above the Drug Manufacturers median (#510 of 955)
No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score
Get the complete analysis for LBTSF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LBTSF has been successfully added to your 
